Endocrinology Unit, Medical Department, Maggiore-Bellaria Hospital, Azienda-Usl Bologna, Bologna, Italy.
Unit of Internal Medicine and Endocrinology, Laboratory for Endocrine Disruptors, Istituti Clinici Scientifici Maugeri IRCCS, 27100, Pavia, Italy.
J Endocrinol Invest. 2021 Dec;44(12):2535-2544. doi: 10.1007/s40618-021-01590-9. Epub 2021 May 25.
Thyroid disorders, both overt and subclinical, are highly prevalent conditions in the general population. Although a clear relationship between overt thyroid dysfunctions and cardiovascular complications has long been established, data regarding subclinical thyroid dysfunction are by far more controversial.
The present review will be aimed at providing a summary of most recent evidence coming from meta-analyses regarding the complex relationship between thyroid dysfunction and cardiovascular disease.
The review will summarize, in the first part, the physiopathological link between thyroid hormone imbalances and the cardiovascular system. In the second part the review will outline the evidence coming from meta-analyses regarding the cardiovascular risk related with both overt and subclinical thyroid dysfunctions. Particular attention will be put towards studies showing data stratified for patient's age, TSH levels and pre-existing cardiovascular disease. Finally, an overview regarding the effects of specific therapy for subclinical thyroid diseases in terms of amelioration of cardiovascular outcomes will be included.
甲状腺疾病,无论是显性的还是亚临床的,在普通人群中都非常普遍。尽管显性甲状腺功能障碍与心血管并发症之间的明确关系早已确立,但关于亚临床甲状腺功能障碍的数据到目前为止仍然存在更多争议。
本综述旨在总结最近来自荟萃分析的关于甲状腺功能障碍与心血管疾病之间复杂关系的证据。
在第一部分,综述将总结甲状腺激素失衡与心血管系统之间的生理病理联系。在第二部分,综述将概述来自荟萃分析的关于显性和亚临床甲状腺功能障碍相关心血管风险的证据。特别关注针对患者年龄、TSH 水平和已有心血管疾病进行分层的数据的研究。最后,将概述亚临床甲状腺疾病的特定治疗对改善心血管结局的影响。